Clinical trial
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular…
NCT00347399 · Asociación para Evitar la Ceguera en México, Other · Terminated
Key facts
| NCT number | NCT00347399 |
|---|---|
| Title | Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration |
| Official title | Effects of Intravitreal Injection of Bevacizumab in Combination With Verteporfin Photodynamic Therapy |
| Lead sponsor | Asociación para Evitar la Ceguera en México, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age Related Macular Degeneration |
| Intervention type | Drug, Procedure |
| Interventions | bevacizumab intravitreal injection, verteporfin photodynamic therapy |
| Enrollment | 25 |
| Start date | Mar 1, 2006 |
| Primary completion | Jun 30, 2006 |
| Completion | Jun 30, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | May 30, 2024 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: